Skip to main content
Veterinary Medicines

Nafpenzal DC tőgyinfúzió

Authorised
  • Benzylpenicillin procaine
  • Nafcillin sodium
  • Dihydrostreptomycin sulfate

Product identification

Medicine name:
Nafpenzal DC tőgyinfúzió
Active substance:
  • Benzylpenicillin procaine
  • Nafcillin sodium
  • Dihydrostreptomycin sulfate
Target species:
  • Cattle
Route of administration:
  • Intramammary use

Product details

Active substance and strength:
  • Benzylpenicillin procaine
    100.00
    milligram(s)
    /
    1.00
    gram(s)
  • Nafcillin sodium
    33.33
    milligram(s)
    /
    1.00
    gram(s)
  • Dihydrostreptomycin sulfate
    33.33
    milligram(s)
    /
    1.00
    gram(s)
Pharmaceutical form:
  • Intramammary suspension
Withdrawal period by route of administration:
  • Intramammary use
    • Cattle
      • Milk
        43
        day
      • Meat and offal
        40
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ51RC23
Authorisation status:
  • Valid
Authorised in:
This information is not available for this product.
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Intervet International B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • INTERVET INTERNATIONAL B.V.
Responsible authority:
  • Directorate Of Veterinary Medicinal Products
Authorisation number:
This information is not available for this product.
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Hungarian (PDF)
Published on: 6/03/2024

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Hungarian (PDF)
Published on: 6/03/2024
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."